Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment

Journal of Psychiatric Practice
Kenneth Belzer, F R Schneier

Abstract

The purpose of this review is to provide a clinically relevant analysis of issues concerning comorbidity among anxiety and depressive disorders. The co-occurrence of social anxiety disorder (SAD) and generalized anxiety disorder (GAD) with depressive disorders is highlighted as an illustration. Data on prevalence, rates of comorbidity, order of onset, course, and functional impairment associated with these disorders, in both the general population and clinical samples, are examined. The second half of the review focuses on discussion of practical issues concerning assessment and treatment of comorbid anxiety and depressive syndromes. Available evidence suggests that comorbidity among SAD, GAD, and the depressive disorders is substantial and pervasive. Co-occurrence of these syndromes is typically characterized by a chronic course with clinically significant impairment in social and occupational functioning. SAD and GAD precede the onset of major depression in a majority of cases and appear to be risk factors for developing major depression. Clinicians encountering patients with primary complaints of anxiety or depression should carefully assess for the presence of comorbid symptoms and syndromes. Treatment outcome research sugg...Continue Reading

References

Dec 1, 1992·Journal of Consulting and Clinical Psychology·T A Brown, D H Barlow
Apr 1, 1992·Archives of General Psychiatry·F R SchneierM M Weissman
Feb 1, 1991·Journal of Affective Disorders·M Van AmeringenD Donison
Jul 11, 1991·Comprehensive Psychiatry·M GarveyB Cook
Aug 1, 1990·Journal of Abnormal Psychology·W C SandersonD H Barlow
Mar 1, 1995·Archives of General Psychiatry·S MannuzzaA J Fyer
Jul 1, 1994·Archives of General Psychiatry·G D TollefsonL A Genduso
Dec 1, 1993·Journal of Clinical Psychopharmacology·J R DavidsonW H Wilson
May 1, 1994·Archives of General Psychiatry·H U WittchenW W Eaton
Aug 1, 1993·The American Journal of Psychiatry·O Brawman-MintzerJ C Ballenger
May 1, 1993·Psychological Medicine·K S KendlerL J Eaves
Feb 1, 1993·Archives of General Psychiatry·C N ChenM Fung
Apr 1, 1993·The American Journal of Psychiatry·A O MassionM B Keller
Apr 1, 1993·Archives of General Psychiatry·A J FyerD F Klein
Apr 1, 1993·Journal of Consulting and Clinical Psychology·D L Chambless, M M Gillis
Sep 1, 1995·Psychological Medicine·M A RoyK S Kendler
Nov 1, 1996·The American Journal of Psychiatry·W A Brown
Jun 1, 1996·International Clinical Psychopharmacology·H U Wittchen, E Beloch
May 1, 1997·Journal of Anxiety Disorders·D L ChamblessC R Glass
Oct 6, 1997·Biological Psychiatry·M FavaJ F Rosenbaum
Nov 18, 1998·International Journal of Geriatric Psychiatry·A T BeekmanW van Tilburg
Dec 23, 1998·Archives of General Psychiatry·R G HeimbergD F Klein
Mar 13, 1999·The Journal of Clinical Psychiatry·D DavidT A Mellman
Apr 20, 1999·Depression and Anxiety·J D CarterP F Sullivan
May 20, 1999·Biological Psychiatry·M A HertzbergJ R Davidson
Jun 5, 1999·Journal of Affective Disorders·G ParkerG Gladstone
Aug 10, 1999·Journal of Clinical Psychopharmacology·A C PandeS M Sutherland
Mar 31, 2000·Comprehensive Psychiatry·M FavaJ F Rosenbaum
May 18, 2000·JAMA : the Journal of the American Medical Association·D H BarlowS W Woods
Dec 1, 2001·The American Journal of Psychiatry·D J KatzelnickC P Helstad
Sep 19, 2002·Journal of Psychopharmacology·Shamsah B SonawallaMaurizio Fava
Dec 31, 2002·Journal of Psychopharmacology·Stewart D BarnettJonathan R T Davidson
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jun 24, 2003·Depression and Anxiety·Franklin R SchneierMichael R Liebowitz
Jun 26, 2003·The Journal of Clinical Psychiatry·Ulla LepolaCarol Austin
Sep 16, 2003·Clinical Psychology Review·Derek R HopkoGeorg H Eifert
Sep 30, 2003·Journal of Psychopharmacology·Mark H PollackMichael W Otto

❮ Previous
Next ❯

Citations

Jan 17, 2007·Psychopharmacology·Younglim LeeAnantha Shekhar
Feb 25, 2009·Journal of Abnormal Child Psychology·Phillip J TullyAnthony J Venning
Jun 7, 2005·Current Psychiatry Reports·Christine Mohr, Olaf Blanke
Feb 14, 2008·Current Psychiatry Reports·Amber M Gum, Jennifer S Cheavens
Jun 12, 2010·Journal of Anxiety Disorders·Stephen E MelkaBenjamin F Rodriguez
Jul 22, 2009·Psychological Review·Paul W Andrews, J Anderson Thomson
Apr 15, 2010·The International Journal of Clinical and Experimental Hypnosis·Assen Alladin
Dec 23, 2011·Pain Research and Treatment·M LundbergM J Simmonds
Aug 21, 2013·Health and Quality of Life Outcomes·Fatemeh BazarganipourSoghrat Faghihzadeh
Dec 23, 2011·Parkinson's Disease·Kristine K Hanna, Alice Cronin-Golomb
Jan 31, 2016·Medical Hypotheses·A J M Loonen, S A Ivanova
Sep 14, 2010·Journal of Anxiety Disorders·Kristy L Dalrymple, Mark Zimmerman
Apr 24, 2010·Behavior Therapy·Megan M KellyKatharine A Phillips
Jun 10, 2009·International Journal of Methods in Psychiatric Research·Ingvar BjellandHelena C Kraemer
May 29, 2012·Acta Psychiatrica Scandinavica·K Beesdo-BaumH-U Wittchen
Jul 4, 2006·Frontiers in Neuroendocrinology·Maureen P Howell, Louis J Muglia
Aug 14, 2012·Parkinson's Disease·Anne Marie BonnetMarie Vidailhet
Sep 25, 2012·Psychiatry Research·Megan M KellyKatharine A Phillips
Feb 11, 2014·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowHans Eriksson
Aug 11, 2012·Journal of Affective Disorders·Amy FarabaughMichael E Thase
Dec 26, 2006·Journal of Affective Disorders·Kristy L Dalrymple, Mark Zimmerman
Jan 6, 2015·Journal of Affective Disorders·Anthony M TarescavageManfred H M van Dulmen
Feb 12, 2011·Psychiatry Research·Kristy L Dalrymple, Mark Zimmerman
Jan 22, 2013·Journal of Psychosomatic Research·Kimberley J SmithNorbert Schmitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.